previous compound ID: 2228 next compound
InChIKey: ULSDMUVEXKOYBU-ZDUSSCGKSA-N
SMILES: CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"GW Carlile" "JW Hanrahan" "R Robert" "J Liao" "E Matthes" "J Goepp" "B Kus" "DY Thomas" "D Rotin" "SD Macknight"

chemical graph of compound 2228





CID is 60857
synonyms found at PubChem are:
zolmitriptan, 139264-17-8, Zomig, Zomigoro, Zomigon, Flezol, 311C90, Zomig-ZMT, AscoTopand, Zomig Nasal Spray, Zomig ZMT, zolmitriptane, zolmitriptanum, AscoTop, Zolmitriptan [USAN], zipton, zominat, UNII-2FS66TH3YW, (S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one, Zolmitriptan (Zomig), Zomig (TN), Zolmitriptan RapidFilm, BW-311C90, 2FS66TH3YW, CHEMBL1185, (S)-4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone, (S)-4-((3-(2-(Dimethylamino)ethyl)indol-5-yl)methyl)-2-oxazolidinone, 4-((3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)methyl)-2-oxazolidinone, CHEBI:10124, C16H21N3O2, KS-5072, (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one, (S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, (4S)-4-((3-(2-(DIMETHYLAMINO)ETHYL)-1H-INDOL-5-YL)METHYL)-2-OXAZOLIDINONE, (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, (4S)-4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one, DSSTox_CID_25933, DSSTox_RID_81232, DSSTox_GSID_45933, Rapimelt, 4-[[3-(2-dimethylaminoethyl)-1H-indol-5-yl]methyl]oxazolidin-2-one, 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-, (S)-, CPD000449310, SMR000449310, CAS-139264-17-8, Zolmitriptan [USAN:INN:BAN], (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one, NCGC00095155-01, Zomigoro (TN), Zomigon (TN), AscoTop (TN), Spectrum2_000728, D0NG7O, GTPL60, AC1L1U2E, SCHEMBL33336, MLS000758208, MLS001424172, BIDD:GT0040, SPECTRUM1505281, SPBio_000656, Zolmitriptan (JAN/USAN/INN), DTXSID8045933, KS-00000HAJ, ZINC15515, Zolmitriptan, >=98% (HPLC), Zomig;Zomigon;AscoTopand;Zomigoro, MolPort-003-666-626, ULSDMUVEXKOYBU-ZDUSSCGKSA-N, HMS1922B04, HMS2052K17, HMS2093O14, HMS2235I22, HMS3714H11, Pharmakon1600-01505281, ACT04392, BCP10513, HY-B0229, ZMT, Tox21_111455, BDBM50033383, CCG-38993, MFCD00871503, NSC760383, s1649, AKOS015850706, Tox21_111455_1, AB07628, AN-5272, AT-3239, CS-2179, DB00315, NC00382, NSC-760383, (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl]ethylamine, NCGC00263884-02, NCGC00263884-03, NCGC00263884-08, AK-47834, BC206232, KB-62428, SAM001246841, SAM001247064, SC-17326, SBI-0206762.P001, AB2000194, LS-100559, ST2407794, B2261, FT-0631159, 64Z178, A-2479, C07218, D00415, J10141, AB00698244-05, AB00698244_06, SR-05000001693, J-007257, SR-05000001693-1, Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan, Zolmitriptan, United States Pharmacopeia (USP) Reference Standard, (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one, (S) -N,N-Dimethyl-2- [5- (2-oxo-1,3-oxazolidin-4-ylmethyl) -1H -indol-3-yl]ethylamine, (S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one, (S)-4-(3-[2-(DIMETHYLAMINO)ETHYL]-5-INDOLYLMETHYL)OXAZOLIDIN-2-ONE, (S)-N,N-Dimethyl-2-[5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H -indol-3-yl]ethylamine, 2-Oxazolidinone, 4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-, (4S)-